PURPOSE: Purpose of this study was to determine the accuracy of prediction of non-sentinel lymph node (NSLN) involvement in sentinel node (SLN)-positive breast cancer patients based on protein concentrations measured in lysates from initially taken breast biopsies. METHODS: Data on protein expression, previously generated by multiplexed bead-based immunoassays, were analysed by multivariate logistic regression to define parameter sets of value to predict NSLN involvement. Receiver-operator characteristics (ROCs) were calculated as indicators of diagnostic significance. RESULTS: Analyses of data from all patients (n = 99) resulted in parameter sets that allowed direct prediction of the NSLN status with a ROC area under the curve (AUC) of 0.83. The clinically most relevant prediction of NSLN status in SLN-positive patients (n = 37) based on only seven parameters (including TIMP-2 as the most relevant single value) was possible with high accuracy indicated by an AUC of 0.89. CONCLUSIONS: Parallel assessment of protein concentrations in breast biopsies is a highly promising approach to predict nodal involvement and even the NSLN status in SLN-negative breast cancer patients. Such diagnostic information could substantially reduce the number of completion axillary lymph node dissections in clinical practice.
PURPOSE: Purpose of this study was to determine the accuracy of prediction of non-sentinel lymph node (NSLN) involvement in sentinel node (SLN)-positive breast cancerpatients based on protein concentrations measured in lysates from initially taken breast biopsies. METHODS: Data on protein expression, previously generated by multiplexed bead-based immunoassays, were analysed by multivariate logistic regression to define parameter sets of value to predict NSLN involvement. Receiver-operator characteristics (ROCs) were calculated as indicators of diagnostic significance. RESULTS: Analyses of data from all patients (n = 99) resulted in parameter sets that allowed direct prediction of the NSLN status with a ROC area under the curve (AUC) of 0.83. The clinically most relevant prediction of NSLN status in SLN-positive patients (n = 37) based on only seven parameters (including TIMP-2 as the most relevant single value) was possible with high accuracy indicated by an AUC of 0.89. CONCLUSIONS: Parallel assessment of protein concentrations in breast biopsies is a highly promising approach to predict nodal involvement and even the NSLN status in SLN-negative breast cancerpatients. Such diagnostic information could substantially reduce the number of completion axillary lymph node dissections in clinical practice.
Authors: Andraz Perhavec; Maja Pohar Perme; Marko Hocevar; Nikola Besić; Janez Zgajnar Journal: Breast Cancer Res Treat Date: 2010-01 Impact factor: 4.872
Authors: Angela Katz; Andrzej Niemierko; Irene Gage; Sheila Evans; Margaret Shaffer; Thomas Fleury; Frederick P Smith; Peter E Petrucci; Richard Flax; Cynthia Drogula; Colette Magnant Journal: J Surg Oncol Date: 2006-06-01 Impact factor: 3.454
Authors: G Houvenaeghel; C Nos; S Giard; H Mignotte; B Esterni; J Jacquemier; M Buttarelli; J-M Classe; M Cohen; P Rouanet; F Penault Llorca; P Bonnier; F Marchal; J-R Garbay; J Fraisse; P Martel; E Fondrinier; C Tunon de Lara; J-F Rodier Journal: Eur J Surg Oncol Date: 2008-11-28 Impact factor: 4.424
Authors: Georg Sauer; Nicole Schneiderhan-Marra; Cornelia Kazmaier; Kathrin Hutzel; Karin Koretz; Rainer Muche; Rolf Kreienberg; Thomas Joos; Helmut Deissler Journal: Clin Cancer Res Date: 2008-06-01 Impact factor: 12.531
Authors: Karl Y Bilimoria; David J Bentrem; Nora M Hansen; Kevin P Bethke; Alfred W Rademaker; Clifford Y Ko; David P Winchester; David J Winchester Journal: J Clin Oncol Date: 2009-04-13 Impact factor: 44.544